ClinicalTrials.gov
public full text
Public Domain
Effect of Momordica Charantia Administration on Anthropometric Indicators in Patients With Obesity
Momordica charantia has shown to exert anti-obesity effects through numerous mechanisms of action described in preclinical studies. Important reductions in body weight and other anthropometric indicators have been reported in clinical trials. However, these beneficial effects of Momordica charantia on obesity have been observed mainly in type 2 diabetes mellitus patients. The purpose of this study is to evaluate the effect of Momordica charantia administration on anthropometric indicators in patients with obesity.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effects of Palatinose™ on Weight Management and Body Composition#855727
- The Impact of Glycemic Index Education on Lowering Dietary GI in Gestational Diabetes Mellitus#460019
- A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus#1337318
- The Influence of Advanced Age, Obesity and Diabetes Type on Course and Outcome of Pregnancy With Diabetes Mellitus.#1059083
- A Study to Determine the Effects of MK0557 in Obese Subjects (0557-006)(COMPLETED)#967517
Record · ID 1339794
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive